Trajectory of PD-L1 expression in a patient underwent neoadjuvant chemo-immunotherapy for resectable NSCLC

MeSH terms

• Aged
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• B7-H1 Antigen* / metabolism
• Carcinoma, Non-Small-Cell Lung* / drug therapy
• Carcinoma, Non-Small-Cell Lung* / metabolism
• Carcinoma, Non-Small-Cell Lung* / pathology
• Carcinoma, Non-Small-Cell Lung* / therapy
• Humans
• Immune Checkpoint Inhibitors / therapeutic use
• Immunotherapy* / methods
• Lung Neoplasms* / drug therapy
• Lung Neoplasms* / metabolism
• Lung Neoplasms* / pathology
• Lung Neoplasms* / therapy
• Male
• Middle Aged
• Neoadjuvant Therapy* / methods